Genetic variation in gonadal impairment in female survivors of childhood cancer: A PanCareLIFE study protocol

Improved risk stratification, more effective therapy and better supportive care have resulted in survival rates after childhood cancer of around 80% in developed countries. Treatment however can be harsh, and three in every four childhood cancer survivors (CCS) develop at least one late effect, such as gonadal impairment.